Enzo Biochem Says Identified Unauthorized Access To Or Acquisition Of Clinical Test Information Of Approximately 2.47M Individuals
Portfolio Pulse from Benzinga Newsdesk
Enzo Biochem (ENZ) experienced a ransomware attack on April 6, 2023, which led to unauthorized access or acquisition of clinical test information of approximately 2.47 million individuals.
May 30, 2023 | 8:44 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Enzo Biochem's ransomware attack compromised the clinical test information of 2.47 million individuals, potentially affecting the company's reputation and stock price.
The ransomware attack on Enzo Biochem directly compromised the clinical test information of 2.47 million individuals. This security breach could negatively affect the company's reputation, leading to a potential decline in its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100